Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 14992 total
DigitalBridge Group enters the final weeks of Q3 with a mildly constructive price tape and a steady drift higher in short positions — a combination that hasn't yet reached tension but is worth tracking. The short-side…
AUGO enters the week with a notable divergence — the stock is up 8% in seven days, yet short sellers are adding positions at the fastest pace in months. The clearest tension is in short positioning. Short interest has…
The Trade Desk heads into its October 19 earnings date as one of the more contested names in digital advertising — a stock down 63% year-to-date, carrying nearly a fifth of its float short, and with a history of…
Madrigal Pharmaceuticals enters the final week of September with a fresh analyst initiation pulling in one direction and a month-long rise in short positioning pulling in the other. Citi's Eric Joseph launched coverage…
Smurfit Westrock closed Tuesday at $46.45, up 6.3% on the week — outpacing every name in its peer group and reviving a stock that lost nearly 6% over the prior month. The relative outperformance is the week's clearest…
Pulse Biosciences enters the final week of September with a wave of fresh analyst coverage colliding against a stock that has pulled back 4.5% on the week and carries a meaningful short position — yet the lending…
Bank7 Corp. heads into its October 15 earnings date with a fresh analyst upgrade on the tape and short interest running at a five-week high — a small but notable divergence worth watching. The most immediate catalyst…
Dream Finders Homes heads into October with a striking tension: directors buying the stock persistently on the way down, while short sellers show no sign of backing off at 20.7% of the free float. The insider buying is…
Altimmune enters the final stretch of September with a curious split: its short interest remains one of the heaviest in small-cap biotech, yet the bears have been quietly retreating all week while the stock quietly…
SPCX heads into the final days of September caught in a genuine tug-of-war: short interest at a six-week high, the stock up 7.8% on the week, and neither side showing any sign of capitulating. The short-side story…
AVTX enters the week with one of the most extreme short positioning profiles in small-cap biotech — yet the borrow market tells a notably different story from what the headline short interest figure…
Axsome Therapeutics enters the final weeks of Q3 with a sharp divergence at its core: the Street is turning more constructive on the CNS drug developer, yet options traders have moved to their most defensive posture in…
Wave Life Sciences enters the final stretch of September with a fresh analyst blow and a stock trading near the lower end of a brutal year — a setup where the Street's conviction and the money behind the name are…
XLRE has lost 5.7% over the past month and options traders are now the most cautious they've been in weeks — the clearest tension heading into the final stretch of September. The options market tells the sharpest…
Lumentum Holdings enters the back half of September with a notable internal tension: the stock has climbed 13% over the past month and sits at $945.67, yet short sellers are quietly adding back positions they spent…
CIBR has continued the trend flagged earlier this week — the borrow market that was already tightening is now considerably more stressed, even as the ETF adds another 1.6% on the week to trade near $102.58. The lending…
PayPal heads into the final week of September with a 14% one-month slide to $52.89 sitting in uncomfortable contrast to a short base that is rapidly unwinding — a setup where the bears appear to be losing conviction…
Glaukos Corporation heads into its October 28 quarterly print with a notable disconnect: the Street just got more bullish, but the stock is down 7% on the week. The freshest analyst move sharpens the contrast.…
SHOP is up 14% on the week to $147.74, yet the options market is flashing its most defensive posture in over a year — a divergence that makes this week's setup unusually interesting. The clearest signal comes from…
MDT closed the week at $90.77, down 3.2% on the week and roughly 2.8% over the past month, even as the analyst community raised targets in bulk following the company's most recent earnings print. The disconnect between…
